Abstract
Nanotechnology has emerged as a promising field in cancer treatment, particularly for its ability to improve the efficiency and specificity of drug delivery systems. Targeted drug delivery using nanocarriers enables the selective delivery of therapeutic agents to cancer cells, minimizing damage to healthy tissues and reducing side effects. This article reviews the recent advancements in nanotechnology for targeted drug delivery systems, highlighting the development of nanoparticles, liposomes, dendrimers, and nanostructured carriers for cancer treatment. It also discusses the challenges and future directions for nanomedicine in oncology, including issues related to biocompatibility, targeting efficiency, and clinical translation.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Dr. Olivia Patel, Dr. Michael Zhou (Author)